Moffitt Notice of Blackbaud Data Incident. Learn More
Clinical Trials Search
Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes
The purpose of the study is to assess self-reported side effects and neurocognitive (brain, mood and thinking) functioning among patients treated with commercial axi-cel therapy.
Aim 1: To evaluate longitudinal changes in neurocognition following axi-cel therapy Aim 2: Describe longitudinal changes in patient-reported outcomes for patients receiving axi-cel cell therapy.